Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases

Cardiovascular Drugs and Therapy
Florian Kronenberg

Abstract

Lipoprotein(a) [Lp(a)] is a highly atherogenic lipoprotein that is under strong genetic control by the LPA gene locus. Genetic variants including a highly polymorphic copy number variation of the so called kringle IV repeats at this locus have a pronounced influence on Lp(a) concentrations. High concentrations of Lp(a) as well as genetic variants which are associated with high Lp(a) concentrations are both associated with cardiovascular disease which very strongly supports causality between Lp(a) concetrations and cardiovascular disease. This method of using a genetic variant that has a pronounced influence on a biomarker to support causality with an outcome is called Mendelian randomization approach and was applied for the first time two decades ago with data from Lp(a) and cardiovascular disease. This approach was also used to demonstrate a causal association between high Lp(a) concentrations and aortic valve stenosis, between low concentrations and type-2 diabetes mellitus and to exclude a causal association between Lp(a) concentrations and venous thrombosis. Considering the high frequency of these genetic variants in the population makes Lp(a) the strongest genetic risk factor for cardiovascular disease identified so far. P...Continue Reading

References

Jul 1, 1992·The Journal of Clinical Investigation·E BoerwinkleH H Hobbs
Oct 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·C SandholzerG Utermann
Nov 17, 1989·Science·G Utermann
Aug 1, 1987·The Journal of Clinical Investigation·G UtermannC Seitz
Mar 1, 1995·The Journal of Clinical Investigation·D J RaderM Grossman
Jul 1, 1993·Human Molecular Genetics·C LacknerH H Hobbs
Jan 1, 1996·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·F KronenbergH Dieplinger
Jun 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·H G KraftG Utermann
Dec 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·F KronenbergG Utermann
Aug 1, 1997·American Journal of Human Genetics·V MooserH H Hobbs
Oct 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·R M LawnL Patthy
Oct 22, 1998·European Journal of Human Genetics : EJHG·A LingenhelG Utermann
Apr 10, 1999·European Journal of Human Genetics : EJHG·M ScholzG Utermann
Aug 4, 1999·Current Opinion in Lipidology·H Dieplinger, G Utermann
Feb 17, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·H G KraftG Utermann
Nov 27, 2002·Circulation·J Craig LongeneckerUNKNOWN Choices for Healthy Outcomes in Caring for ESRD
Apr 12, 2003·International Journal of Epidemiology·George Davey Smith, Shah Ebrahim
Mar 17, 2004·Current Opinion in Lipidology·Marlys L Koschinsky, Santica M Marcovina
Apr 1, 2005·Journal of the American Society of Nephrology : JASN·J Craig LongeneckerJosef Coresh
Jul 8, 2005·The New England Journal of Medicine·Sotirios TsimikasPeter B Berger
Nov 4, 2005·European Journal of Human Genetics : EJHG·Konrad SchmidtGerd Utermann
May 29, 2008·Nature Clinical Practice. Cardiovascular Medicine·Frederick F SamahaDaniel J Rader
Jul 3, 2008·Journal of Lipid Research·Claes BergmarkSotirios Tsimikas
Jul 9, 2008·Current Opinion in Lipidology·Sotirios Tsimikas, Joseph L Witztum
Feb 24, 2009·Nature Clinical Practice. Cardiovascular Medicine·Beate R JaegerUNKNOWN Group of Clinical Investigators
Jun 11, 2009·JAMA : the Journal of the American Medical Association·Pia R KamstrupBørge G Nordestgaard
Dec 25, 2009·The New England Journal of Medicine·Robert ClarkeUNKNOWN PROCARDIS Consortium
Mar 12, 2010·The New England Journal of Medicine·Paul W LadensonBo Angelin
May 8, 2010·Journal of the American College of Cardiology·Sebhat ErqouJohn Danesh

❮ Previous
Next ❯

Citations

Apr 4, 2017·Expert Opinion on Investigational Drugs·Gerald H Tomkin, Daphne Owens
Feb 12, 2017·Journal of the American College of Cardiology·Sotirios Tsimikas
Apr 15, 2016·Journal of Lipid Research·Konrad SchmidtGerd Utermann
Nov 3, 2016·Journal of Lipid Research·Børge G Nordestgaard, Anne Langsted
Jan 31, 2018·Journal of Lipid Research·Jemma C HopewellColin Baigent
Jan 8, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Patrick M MoriartySotirios Tsimikas
Aug 26, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Archna BajajUNKNOWN Chronic Renal Insufficiency Cohort (CRIC) Study Investigators*
Nov 20, 2016·Stroke; a Journal of Cerebral Circulation·Kristin S LangeMartin Ebinger
Jan 23, 2019·Circulation·Guillaume ParéUNKNOWN INTERHEART Investigators
Dec 22, 2017·Critical Reviews in Clinical Laboratory Sciences·Corey A ScipioneMichael B Boffa
Jun 10, 2019·Bulletin of Experimental Biology and Medicine·O I Afanas'evaS N Pokrovsky
Mar 6, 2019·Clinical Chemistry and Laboratory Medicine : CCLM·Barbara LombardoOlga Scudiero
Nov 30, 2019·Experimental and Therapeutic Medicine·Jing YaoYanbei Sun
Dec 1, 2019·Journal of Clinical Medicine·Natalie C WardGerald F Watts
Oct 20, 2018·Respirology : Official Journal of the Asian Pacific Society of Respirology·Ross Vlahos
Mar 13, 2019·Clinical Research in Cardiology Supplements·Florian Kronenberg
Mar 7, 2019·Clinical Research in Cardiology Supplements·U JuliusS R Bornstein
Jul 25, 2018·Respirology : Official Journal of the Asian Pacific Society of Respirology·Jonghoo LeeJae-Uk Song
May 13, 2019·Journal of Assisted Reproduction and Genetics·Charalambos VlachopoulosDimitrios Tousoulis
Aug 2, 2019·Current Cardiology Reports·Nestor Vasquez, Parag H Joshi
Jul 17, 2020·Current Atherosclerosis Reports·Dhruv MahttaSalim S Virani
Feb 26, 2020·Current Opinion in Cardiology·Hapizah Md NawawiGerald F Watts
Oct 21, 2020·Journal of Cardiovascular Development and Disease·Olga AfanasievaSergei Pokrovsky
Sep 11, 2020·Journal of Lipid Research·Alice SantonastasoClaudia Scotti
Aug 3, 2019·Journal of Clinical Lipidology·Chiara PavanelloRosellina Margherita Mancina

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis
genotyping
antisense oligonucleotide

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.